A carregar...

Activation of Alternate Prosurvival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts

Acquired drug resistance represents a major obstacle to using sunitinib for the treatment of solid tumors. Here, we examined the cellular and molecular alterations in tumors that are associated with acquired brain tumor resistance to sunitinib by using an in vivo model. U87MG tumors obtained from nu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhou, Qingyu, Lv, Hua, Mazloom, Amin R., Xu, Huilei, Ma'ayan, Avi, Gallo, James M.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Pharmacology and Experimental Therapeutics 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3477209/
https://ncbi.nlm.nih.gov/pubmed/22869928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.112.196097
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!